Neuravi Limited
Clinical trials sponsored by Neuravi Limited, explained in plain language.
A medical device company focused on neurovascular therapies, acquired by Johnson & Johnson.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New catheter aims to clear stroke clots faster Results expected Apr 2027 (estimated)